HOLTON; Simon
Patent Applications and Registrations
Patent applications and USPTO patent grants for HOLTON; Simon.The latest application filed is for "masp inhibitory compounds and uses thereof".
Company Profile
11.17.32
- HOLTON; Simon - Berlin DE
Patent Activity
| Patent | Date |
|---|---|
| Masp Inhibitory Compounds And Uses Thereof App 20210246166 - BIERER; Donald ; et al. | 2021-08-12 |
| 4-(3-amino-6-fluoro-1h-indazol-5-yl)-1,2,6-trimethyl-1,4-dihydropyridine-3- ,5-dic Arbonitrile Compounds For Treating Hyperproliferative Disorders App 20210047297 - SCHULZE; Volker ; et al. | 2021-02-18 |
| Identification And Use Of Erk5 Inhibitor App 20210017174 - NGUYEN; Duy ; et al. | 2021-01-21 |
| Anti-ceacam6 Antibodies And Uses Thereof App 20200181261 - WILLUDA; Jorg ; et al. | 2020-06-11 |
| Anti-ceacam6 Antibodies And Uses Thereof App 20200157214 - WILLUDA; Jorg ; et al. | 2020-05-21 |
| Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases Grant 10,604,532 - Hitchcock , et al. | 2020-03-31 |
| Anti-CEACAM6 antibodies and uses thereof Grant 10,584,167 - Willuda , et al. | 2020-03-10 |
| 3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones Grant 10,428,044 - Graham , et al. October 1, 2 | 2019-10-01 |
| Substituted Benzylindazoles For Use As Bub1 Kinase Inhibitors In The Treatment Of Hyperproliferative Diseases App 20190284206 - HITCHCOCK; Marion ; et al. | 2019-09-19 |
| Benzyl substituted indazoles as BUB1 inhibitors Grant 10,350,206 - Mengel , et al. July 16, 2 | 2019-07-16 |
| Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases Grant 10,266,548 - Hitchcock , et al. | 2019-04-23 |
| Anti-ceacam6 Antibodies And Uses Thereof App 20180162940 - WILLUDA; Jorg ; et al. | 2018-06-14 |
| Amido-substituted Cyclohexane Derivatives App 20180148418 - EIS; Knut ; et al. | 2018-05-31 |
| 2,3-benzodiazepines Grant 9,890,147 - Siegel , et al. February 13, 2 | 2018-02-13 |
| Amido-substituted azole compounds Grant 9,884,063 - Eis , et al. February 6, 2 | 2018-02-06 |
| Benzyl Substituted Indazoles As Bub1 Kinase Inhibitors App 20170305882 - MENGEL; Anne ; et al. | 2017-10-26 |
| Diaminoheteroaryl Substituted Indazoles App 20170283396 - HILGER; Christoph-Stephan ; et al. | 2017-10-05 |
| Heteroaryl Substituted Indazoles App 20170275268 - HITCHCOCK; Marion ; et al. | 2017-09-28 |
| Substituted Cycloalkenopyrazoles As Bub1 Inhibitors For The Treatment Of Cancer App 20170275267 - HITCHCOCK; Marion ; et al. | 2017-09-28 |
| Benzyl Substituted Indazoles As Bub1 Inhibitors App 20170273980 - MENGEL; Anne ; et al. | 2017-09-28 |
| Substituted benzylpyrazoles Grant 9,765,058 - Hitchcock , et al. September 19, 2 | 2017-09-19 |
| Substituted Benzylindazoles For Use As Bub1 Kinase Inhibitors In The Treatment Of Hyperproliferative Diseases App 20170260198 - HITCHCOCK; Marion ; et al. | 2017-09-14 |
| Heteroaryl substituted pyrazoles Grant 9,745,285 - Mengel , et al. August 29, 2 | 2017-08-29 |
| Heteroaryl substituted pyrazoles Grant 9,682,974 - Mengel , et al. June 20, 2 | 2017-06-20 |
| Triazolopyridines Grant 9,676,766 - Schulze , et al. June 13, 2 | 2017-06-13 |
| Substituted benzylpyrazoles Grant 9,643,953 - Hitchcock , et al. May 9, 2 | 2017-05-09 |
| 3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones App 20170101391 - GRAHAM; Keith ; et al. | 2017-04-13 |
| Substituted triazolopyridines Grant 9,555,022 - Schulze , et al. January 31, 2 | 2017-01-31 |
| Amido-substituted Azole Compounds App 20170020886 - EIS; Knut ; et al. | 2017-01-26 |
| Heteroaryl Substituted Pyrazoles App 20160326159 - MENGEL; Anne ; et al. | 2016-11-10 |
| Heteroaryl Substituted Pyrazoles App 20160168130 - HITCHCOCK; Marion ; et al. | 2016-06-16 |
| Heteroaryl Substituted Pyrazoles App 20160145267 - HITCHCOCK; Marion ; et al. | 2016-05-26 |
| Diaminoheteroaryl Substituted Pyrazoles App 20160145239 - HILGER; Christoph-Stephan ; et al. | 2016-05-26 |
| Heteroaryl Substituted Pyrazoles App 20160145238 - MENGEL; Anne ; et al. | 2016-05-26 |
| Diaminoheteroaryl Substituted Indazoles App 20160052912 - HILGER; Christoph-Stephan ; et al. | 2016-02-25 |
| Heteroaryl Substituted Indazoles App 20160046604 - HITCHCOCK; Marion ; et al. | 2016-02-18 |
| 3-heteroaryl Substituted Indazoles App 20160046610 - HITCHCOCK; Marion ; et al. | 2016-02-18 |
| 2,3-benzodiazepines App 20150203483 - Siegel; Stephan ; et al. | 2015-07-23 |
| Substituted Cycloalkenopyrazoles As Bub1 Inhibitors For The Treatment Of Cancer App 20150141372 - Hitchcock; Marion ; et al. | 2015-05-21 |
| Substituted Benzylpyrazoles App 20140315934 - Hitchcock; Marion ; et al. | 2014-10-23 |
| Substituted Benzylindazoles For Use As Bub1 Kinase Inhibitors In The Treatment Of Hyperproliferative Diseases App 20140249133 - Hitchcock; Marion ; et al. | 2014-09-04 |
| Substituted triazolopyridines Grant 8,551,980 - Schulze , et al. October 8, 2 | 2013-10-08 |
| Substituted Triazolopyridines App 20130156756 - Schulze; Volker ; et al. | 2013-06-20 |
| Triazolopyridines App 20120328610 - Schulze; Volker ; et al. | 2012-12-27 |
| Substituted Triazolopyridines App 20120328611 - Schulze; Volker ; et al. | 2012-12-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 